Health
French Pasteur Institute abandon Covid-19 vaccine development after phase 1 trials fail – FRANCE 24
Issued on: 25/01/2021 – 16:47
Frances Pasteur Institute announced on Monday that it is ending the development of its Covid-19 vaccine after trial results proved disappointing. It appears that the vaccine failed to prove its efficacy in phase 1 trials. The phase 1 of their trial that started in August. Although the vaccine was well tolerated by people, it seems like it didnt spark sufficient immune system response, FRANCE 24s Julia Sieger reports.
Continue Reading
-
Business22 hours agoWhy the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
Business23 hours agoDoes Macquarie rate BHP shares a buy after its FY25 results?
-
General18 hours agoMigrants raise concerns over Australia’s English tests for visa applicants
-
Noosa News21 hours agoNew FLC President has regional lens – Proctor